Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Jefferies upgrades Aberdeen to 'buy'

(Sharecast News) - Jefferies upgraded Aberdeen on Thursday to 'buy' from 'hold' and lifted the price target to 215p from 140p following the company's full-year results earlier in the week. On Tuesday, the asset manager said it was putting the missing vowels back into its name after a widely-mocked rebrand to Abrdn four years ago, as it reported a swing into the black.

"The positive reaction to the good FY24 results, encouraging and realistic 2026 targets and the use of the DB surplus to help fund some DC obligations was probably amplified by short covering," Jefferies said.

"Nevertheless, we increase our PT to 215p on our new forecasts and higher multiples ascribed to the operating segments."

The bank said it can see Aberdeen return to growth, underpinned by Interactive Investor in the near turn.

"The cosmetic change to the name is welcome too, upgrade to buy," it said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.